Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods
Abstract Lung cancer is one of the deadliest cancers in the world. Two of the most common subtypes, lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), have drastically different biological signatures, yet they are often treated similarly and classified together as non-small cell lun...
Guardado en:
Autores principales: | Joe W. Chen, Joseph Dhahbi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d922fe599804156960b1b7215fec9f0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Na Li, et al.
Publicado: (2021) -
Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Jing Ning, et al.
Publicado: (2021) -
Prognostic Value of Telomeric Zinc Finger-Associated Protein Expression in Adenocarcinoma and Squamous Cell Carcinoma of Lung
por: Gun-Jik Kim, et al.
Publicado: (2021) -
Novel gene signatures for stage classification of the squamous cell carcinoma of the lung
por: Angel Juarez-Flores, et al.
Publicado: (2021) -
Identification of transcriptional subtypes in lung adenocarcinoma and squamous cell carcinoma through integrative analysis of microarray and RNA sequencing data
por: François Fauteux, et al.
Publicado: (2021)